• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Johnson & Johnson (JNJ)

Common Stock
Sell: $207.15|Buy: $207.50|Change: 1.94 (-0.93%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

Address

One Johnson & Johnson Plaza
New Brunswick
NJ
USA
08933

Telephone

+1 781 575-2718

Website

https://www.jnj.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Johnson & Johnson Third Quarter Earnings Conference Call for 20262026-10-14T08:30:00
Johnson & Johnson Third Quarter Earnings Results for 20262026-10-14T00:00:00
Johnson & Johnson Second Quarter Earnings Conference Call for 20262026-07-16T08:30:00
Johnson & Johnson Second Quarter Earnings Results for 20262026-07-16T06:45:00
Johnson & Johnson Annual General Meeting for 20262026-04-24T10:00:00
Johnson & Johnson First Quarter Earnings Conference Call for 20262026-04-15T08:30:00
Johnson & Johnson First Quarter Earnings Results for 20262026-04-15T06:45:00
Johnson & Johnson Annual Report for 20252026-02-13T00:00:00
Johnson & Johnson Fourth Quarter Earnings Results for 20252026-01-21T18:45:00
Johnson & Johnson Fourth Quarter Earnings Conference Call for 20252026-01-21T08:30:00
44th Annual J.P. Morgan Healthcare Conference2026-01-12T11:15:00
Citi’s 2025 Global Healthcare Conference2025-12-03T11:15:00

Previous key dates

NameKey Date
Citi’s 2025 Global Healthcare Conference2025-12-03T11:15:00
Johnson & Johnson to Participate in the 7th Annual Wolfe Research Healthcare Conference2025-11-17T10:40:00
UBS Global Healthcare Conference2025-11-11T11:00:00
Guggenheim Second Annual Healthcare Innovation Conference2025-11-11T10:30:00
Johnson & Johnson Third Quarter Earnings Conference Call for 20252025-10-14T08:30:00
Johnson & Johnson Third Quarter Earnings Result for 20252025-10-14T00:00:00
Bernstein 2nd Annual Healthcare Forum2025-09-24T13:10:00
Morgan Stanley 23rd Annual Global Healthcare Conference2025-09-10T11:30:00
2025 Wells Fargo Healthcare Conference2025-09-03T11:50:00
Johnson & Johnson Second Quarter Earnings Conference Call for 20252025-07-16T08:30:00
Johnson & Johnson Second Quarter Earnings Results for 20252025-07-16T06:45:00
Goldman Sachs 46th Annual Global Healthcare Conference2025-06-11T15:20:00
Bernstein’s 41st Annual Strategic Decisions Conference2025-05-28T09:00:00
Johnson & Johnson to Participate in the 2025 RBC Capital Markets Global Healthcare Conference2025-05-20T13:35:00
BofA Securities 2025 Healthcare Conference2025-05-13T13:40:00
Johnson & Johnson Annual General Meeting for 20252025-04-25T10:00:00
Johnson & Johnson First Quarter Earnings Conference Call for 20252025-04-15T08:30:00
Johnson & Johnson First Quarter Earnings Results for 20252025-04-15T06:45:00
45th Annual TD Cowen Healthcare Conference2025-03-04T11:10:00
Johnson & Johnson Annual Report for 20242025-02-13T00:00:00
Johnson & Johnson Fourth Quarter Earnings Conference Call for 20242025-01-22T08:00:00
Johnson & Johnson Fourth Quarter Earnings Result for 20242025-01-22T00:00:00
43rd Annual J.P. Morgan Healthcare Conference2025-01-13T12:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.